Wednesday, Mar 26, 2025 · SEC filings
What the smart money revealed on Mar 26
491 insider filings came in. We hid 77 planned (10b5-1) sellers and 339 people whose filings were routine, like grants and tax withholding.
Immunome (IMNM) President and CEO Clay Siegall bought $999K
137,100 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 6 checked quarters beat the typical stock 6 months later.
F&G Annuities & Life (FG) Director Celina Doka bought $106K
3,000 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 3 checked quarters beat the typical stock 6 months later.
Prospect Capital (PSEC) CEO John Barry bought $102K
24,000 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 6 checked quarters beat the typical stock 6 months later.
Contango ORE (CTGO) President and CEO Rick Van Nieuwenhuyse bought $99.8K
10,000 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 3 checked quarters beat the typical stock 6 months later.
Gitlab (GTLB) Director Matthew Jacobson sold $8M
Not marked as a planned 10b5-1 sale. Sold 6% of the shares they held directly. Still holds 2.62M shares.
Main Street Capital (MAIN) CEO Dwayne Hyzak sold $6.97M
Not marked as a planned 10b5-1 sale. Sold 23% of the shares they held directly. Still holds 402,371 shares.
Photronics (PLAB) Director Walter Fiederowicz sold $216K
Not marked as a planned 10b5-1 sale. Sold 25% of the shares they held directly. Still holds 29,548 shares.
Show 13 more real buys
Show 34 more real sales
13F season
Holdings as of Dec 31, 2024 were due Feb 14
81 funds have filed. 58 filed for the quarter before.
Biggest real insider buys, Mar 20–26
Open-market buys by officers and directors, filed in the 7 days up to Mar 26.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.